ArticleIJTLD open2026
Development and validation of a primary care-accessible risk prediction model for severe pulmonary TB.
Article in IJTLD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChina has a high TB burden and limited primary care. We therefore developed a risk prediction model using routine clinical and lab indicators to flag severe TB cases early.
methodsIn a case-control study of 2,012 TB patients (499 severe, 1,513 non-severe) from four hospitals (2012-2022), patients were split into training (n = 1,408) and validation (n = 604) sets. Univariable and multivariable logistic regression identified predictors to build a nomogram (i.e., a tool that integrates patient-specific data to predict the probability of a specific clinical event), with model performance assessed using receiver operating characteristic (ROC) curves, calibration, and decision curves.
resultsMultivariable analysis identified seven independent predictors: advanced age, history of TB, lymphocytopenia, monocytosis, neutrophilia, hyponatremia, and hypoalbuminemia. The area under the ROC curve (AUC) for the training set was 0.834 (95% confidence interval [CI]: 0.796-0.872), with a sensitivity of 89.0% and specificity of 63.4%; the validation set AUC was 0.807 (95% CI: 0.746-0.867), with sensitivity 82.0% and specificity 71.7%. The calibration curve showed high consistency between predicted probabilities and actual observations. Decision curve analysis demonstrated clinical net benefit of the model within the threshold probability range of 5%-95%.
conclusionThis model, based on routine indicators, effectively identifies high-risk severe TB cases, offering a practical and cost-efficient tool for early patient stratification in primary care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.